Order Article Reprints

Kiouri DP, Ntallis C, Kelaidonis K, Peana M, Tsiodras S, Mavromoustakos T, Giuliani A, Ridgway H, Moore GJ, Matsoukas JM, et al. Network-Based Prediction of Side Effects of Repurposed Antihypertensive Sartans against COVID-19 via Proteome and Drug-Target Interactomes. Proteomes. 2023; 11(2):21. https://doi.org/10.3390/proteomes11020021

Kiouri, Despoina P., Charalampos Ntallis, Konstantinos Kelaidonis, Massimiliano Peana, Sotirios Tsiodras, Thomas Mavromoustakos, Alessandro Giuliani, Harry Ridgway, Graham J. Moore, John M. Matsoukas, and et al. 2023. "Network-Based Prediction of Side Effects of Repurposed Antihypertensive Sartans against COVID-19 via Proteome and Drug-Target Interactomes" Proteomes 11, no. 2: 21. https://doi.org/10.3390/proteomes11020021

Kiouri, D. P., Ntallis, C., Kelaidonis, K., Peana, M., Tsiodras, S., Mavromoustakos, T., Giuliani, A., Ridgway, H., Moore, G. J., Matsoukas, J. M., & Chasapis, C. T. (2023). Network-Based Prediction of Side Effects of Repurposed Antihypertensive Sartans against COVID-19 via Proteome and Drug-Target Interactomes. Proteomes, 11(2), 21. https://doi.org/10.3390/proteomes11020021